Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Losartan is an angiotensin II receptor blocker (ARB) used primarily to treat high blood pressure (hypertension), reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, and manage kidney disease in people with type 2 diabetes and a history of hypertension. It works by selectively blocking the binding of angiotensin II to the AT1 receptor, preventing vasoconstriction and aldosterone secretion, which leads to relaxation of blood vessels, reduced blood pressure, decreased workload on the heart, and renal protection. Losartan is available as an oral tablet or suspension.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on losartan.